Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Functional Technologies Corp FEBTF

Healthcare Biotechnology


GREY:FEBTF - Post by User

Functional Technologies Corp > Functional hires Boucher for in-house
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by dyazon Feb 07, 2013 5:20pm
131 Views
Post# 20954896

RE: RE: RE: Functional hires Boucher for in-house

RE: RE: RE: Functional hires Boucher for in-house

Looks like Maurice Boucher may have started work and he bottom is in as far as price. We all know what is right aboout this science and he certainly knows what was wrong in management before. He can now go about it in the right way without that former ball and chain CEO. I expect a financing then on with the business plan. The news should start coming and we can then get some timelines on the trial results we have been waiting for.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities